TWD
PCVX icon

True Wealth Design’s Vaxcyte PCVX Stock Holding History

True Wealth Design’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34
Closed -$1.11K – 2840
2025
Q2 		$1.11K Buy
34
+32
+1,600% +$1.05K ﹤0.01% 1427
2025
Q1 		$76 Hold
2
– – ﹤0.01% 2286
2024
Q4 		$164 Buy
+2
New +$199 ﹤0.01% 1242

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

True Wealth Design's PCVX Position: Q3 2025 in Review

True Wealth Design sold out of Vaxcyte (PCVX) in Q3 2025, closing a stake of 34 shares — an estimated $1.11K sold.

True Wealth Design first reported a position in PCVX in Q4 2024 and held it in 3 quarters. The position peaked at $1.11K in Q2 2025. 285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • True Wealth Design reported no remaining Vaxcyte position as of Q3 2025 after selling out during the quarter.
  • True Wealth Design sold 34 Vaxcyte shares in Q3 2025, an estimated $1.11K.
  • True Wealth Design first reported a position in Vaxcyte in Q4 2024 and held it in 3 quarters.
  • True Wealth Design's Vaxcyte position peaked at $1.11K in Q2 2025.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.